Month: December 2025
Federal Circuit Dodges Patent Royalty Battle, Transfers Case Over Jurisdiction Hiccup
December 2, 2025
Acorda Therapeutics, Inc. v. Alkermes PLC Authored by: Jeremy J. Gustrowsky In the world of pharmaceutical partnerships, Acorda Therapeutics and Alkermes PLC once teamed up to bring Ampyra—a drug helping multiple sclerosis patients walk better—to market. Alkermes held a key…
Read MoreFederal Circuit Swiftly Dismisses Appeal Outside Its Patent Jurisdiction Wheelhouse
December 2, 2025
Allen v. Stein Authored by: Jeremy J. Gustrowsky In a quick ruling, the U.S. Court of Appeals for the Federal Circuit dismissed an appeal from a pro se litigant, highlighting the court’s narrow focus on patent and related matters rather…
Read MoreFederal Circuit Affirms Dismissal of Mitek’s Declaratory Judgment Suit Against USAA Over Mobile Banking Patents
December 2, 2025
Mitek Sys. v. United Servs. Auto. Ass’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the dismissal of a declaratory judgment action brought by Mitek Systems, Inc. against United Services Automobile Association (USAA) regarding four…
Read MoreFederal Circuit Affirms CRISPR Patent Invalidity in Gene Editing Dispute
December 2, 2025
Agilent Techs., Inc. v. Synthego Corp. Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit upheld a ruling that all claims in two patents owned by Agilent Technologies are unpatentable, dealing…
Read MoreFederal Circuit Vacates PTAB Ruling on Software Patent, Citing Flawed Review of Licensing Deals
December 2, 2025
Ancora Techs., Inc. v. Roku, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit stepped into a patent dispute over technology designed to protect licensed software from unauthorized copying on…
Read MoreFederal Court Sends Back Trademark Battle Over “Aspire” in Banking and Credit Services
December 2, 2025
Apex Bank v. CC Serve Corp Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit partially upheld and partially overturned a ruling from the Trademark Trial and Appeal Board (TTAB) in…
Read MoreFederal Circuit Rules That “Clinically Proven” Label Doesn’t Save Bayer’s Heart Drug Patent from Invalidity
December 2, 2025
Bayer Pharma Aktiengesellschaft v. Mylan Pharms. Inc Authored by: Jeremy J. Gustrowsky In a recent patent dispute over treatments for heart disease, Bayer challenged generic drug makers’ efforts to invalidate its patent on combining low-dose rivaroxaban—a blood thinner—with aspirin to…
Read MorePatent Infringement Win Overturned: Colibri Heart Valve Loses $106 Million Verdict Against Medtronic
December 2, 2025
Colibri Heart Valve LLC v. Medtronic Corevalve, LLC Authored by: Jeremy J. Gustrowsky In a significant patent law decision, the Federal Circuit reversed a $106 million jury verdict in favor of Colibri Heart Valve LLC against Medtronic CoreValve, LLC, ruling…
Read MoreFederal Circuit Affirms Cisco’s Win Over Egenera in Virtual Network Patent Dispute
December 2, 2025
Egenera, Inc. v. Cisco Sys., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit upheld a district court’s ruling that Cisco Systems, Inc. did not infringe Egenera, Inc.’s U.S. Patent No. 7,231,430, which covers technology for…
Read MoreFederal Circuit Narrows “Consisting Essentially Of” in Eye Therapies v. Slayback Pharma Patent Dispute
December 2, 2025
Eye Therapies, LLC v. Slayback Pharma, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent claim interpretation, the Federal Circuit recently reversed a Patent Trial and Appeal Board (PTAB) ruling in Eye Therapies, LLC v. Slayback Pharma,…
Read MoreFederal Circuit Tosses $166 Million Patent Verdict Against AT&T and Nokia Over Faulty Expert Testimony
December 2, 2025
Finesse Wireless LLC v. AT&T Mobility LLC Authored by: Jeremy J. Gustrowsky In a major decision for patent litigation, the Federal Circuit has reversed a $166 million jury verdict against AT&T Mobility LLC and Nokia of America Corporation, finding that…
Read MorePatent Owner’s Deletion of “Stability” Limits Claim Scope in Insecticide Patent Dispute
December 2, 2025
FMC Corp. v. Sharda USA, LLC Authored by: Jeremy J. Gustrowsky In FMC Corp. v. Sharda USA, LLC, the Federal Circuit vacated a preliminary injunction that had barred Sharda from selling its insecticide product, finding that the lower court misinterpreted…
Read More